Intrauterine Contraception

Filter Standards and Guidance documents

FSRH CEU Statement: Mirena 8 years contraception (Jan 2024)

11 January 2024

This CEU statement notes that the Mirena® 52mg LNG-IUD has now been licensed for 8 years for contraception. There has not been an extension to the licensed duration of use when being used for the management of heavy menstrual bleeding, or for endometrial protection as part of hormone replacement therapy. 
 
This supersedes the current advice in the Intrauterine Contraception Guideline.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH New Product Review: Intrauterine Ball (IUBTM) Ballerine® MIDI (February 2019) (Updated April 2023)

11 April 2023

Manufactured by OCON Medical Ltd, the Intrauterine Ball (IUB™) SCu300B MIDI is a copper intrauterine device (Cu-IUD) comprised of copper beads with a total exposed copper surface of 300mm² strung on a flexible Nitinol (nickel/titanium alloy), PET-coated frame. Once the IUB is released from the 3.2mm diameter insertion tube into the uterus it coils into a spherical shape measuring 15mm in diameter. Download the product review in full here.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date

FSRH CEU statement Levosert 6 year license for contraception - Feb 2021

08 February 2021

This statement notes that the Levosert® 52mg LNG-IUS has been licensed for contraceptive use for 6 years. Levosert remains licensed for 5 years for management of heavy menstrual bleeding and is not licensed for endometrial protection as part of HRT.

You are welcome to download our freely available Guideline documents by clicking on the document title above.

This document is up-to-date